<h3>Study Objective</h3> To demonstrate the use of intraureteral indocyanine green (ICG) in gynecologic surgery <h3>Design</h3> Educational video highlighting a surgical technique. <h3>Setting</h3> Academic medical center. <h3>Patients or Participants</h3> Women undergoing laparoscopic pelvic surgery for benign gynecologic indications including both conventional and robotic approaches. We use this in our practice in cases where significant distortion of anatomy from presenting pathology is anticipated or in the setting of patient factors including multiple prior surgeries, radiation, active inflammation, or congenital anomalies. <h3>Interventions</h3> At the start of the procedure, rigid cystoscopy is performed using a 22 French rigid cystoscope. We combine 25 mg of ICG with 10 mL of sterile water (concentration of 2.5 mg/mL). A 5 French ureteral catheter is passed into the ureter up to 20 cm and 5 mL of ICG is gradually injected as the catheter is slowly withdrawn. This process is repeated in the contralateral ureter. Using specialized equipment, near infrared light or laser penetrates the ureter causing the ICG molecules fluoresce and emit near infrared light that is captured and electronically converted to give the ureter a green color. <h3>Measurements and Main Results</h3> The fluorescence of the ICG allows for quick identification of the ureter. The catheter used may have a smallerdiameter than stents, potentially reducing risk of ureteral edema, injury, and obstruction. Indwelling stents also have greater likelihood of thinning the ureteral wall. ICG allows for detection of small full thickness injury that may be missed by stents as extravasation will present in the surrounding tissues. There are fewer externalized foreign bodies intraoperatively for a shorter duration of time, potentially reducing risk of infection or inadvertent injury. Limitations include the need for specialized equipment and possible washout effect with ICG used intravenously or intracervically. <h3>Conclusion</h3> Intraureteral ICG helps identify the ureter intraoperatively during benign gynecologic surgery with low risk of complications and potential benefits in comparison to stents.